Overview

Digoxin Versus Ivabradine in Heart Failure With Reduced Ejection Fraction

Status:
Unknown status
Trial end date:
2014-10-01
Target enrollment:
Participant gender:
Summary
Study hypothesis: Comparing the effect of digoxin and ivabradine in chronic heart failure patients with a left ventricular ejection of 35% or lower and sinus rhythm with heart rate 70 beats per minute or higher, and who are taking maximal dose of a beta blocker if tolerated.
Phase:
Phase 4
Details
Lead Sponsor:
Kocaeli University
Treatments:
Digoxin